Stason Pharmaceuticals, Inc., established in 1994 and based in Irvine, CA is a privately-held, global pharmaceutical company involved in drug development, manufacturing, importation/exportation, licensing and marketing of both generic and branded products.
Our primary area of development is in the area of oncology, and supportive products for the treatment of side effects related to cancer therapy. Due to our focus in the area of oncology, we are experts in the development of cytotoxic products requiring high containment operations for their production. We also provide contract services for non-high containment products.
Additional therapeutic areas include cardiovascular, central nervous system, autoimmune and endocrine disorders.
In 2011, Stason Animal Health (SAH) was formed and currently offers a vertically integrated, value-added platform for drug development, manufacturing, distribution, marketing, and sales of pet health products into veterinary hospitals and retail drug stores.